SEC Tracker
Get the app

Theriva Biologics TOVX

Theriva Biologics to hold special meeting on Nov 18

Proxy statement

Form
DEF 14A
Filed
Importance
Routine
  1. Special meeting scheduled for Nov 18, 2026
  2. Proposing to increase authorized common stock to 500M shares
  3. Ratifying warrant exercise approval for 16,184,560 shares
  4. Proposal to adjourn meeting if needed

Written from the DEF 14A on EDGAR. Check the filing before you rely on it.

Open in the appGet the appView on EDGAR

Get an email when Theriva Biologics files

Only major filings: results, leadership changes, listing notices and other major events, each with the plain-English summary when we have one or the key facts and the EDGAR link. Routine insider filings never email. Confirm once; unsubscribe in one click.

Similar companies

Companies of similar size in SIC 2834 and related industry codes: the same peer list as the financial tables.

  1. Jaguar Health JAGX public float $4M, Jun 30, 2025
  2. Healthy Extracts HYEX public float $4M, Jun 30, 2025
  3. Q/C Technologies QCLS public float $4M, Jun 30, 2025
  4. Polomar Health Services PMHS public float $4M, Jun 30, 2025
  5. Enveric Biosciences ENVB public float $4M, Jun 30, 2025